Real-World Data on the Effectiveness of Ustekinumab and Risankizumab for Crohn’s Disease
<p>Introduction: No real-world studies have compared efficacy of ustekinumab (UST) and risankizumab (RZB) for the treatment of Crohn’s disease (CD). Methods: We retrospectively collected the data of patients with CD treated with UST or RZB between May 2017 and March 2024 at the Institute...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Karger Publishers
2025-01-01
|
| Serier: | Inflammatory Intestinal Diseases |
| Online adgang: | https://karger.com/article/doi/10.1159/000547048 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|